Postpsychotic depression in schizophrenia patients

Kohler, Christian G.; Lallart, Élise

doi:10.1007/s11920-996-0046-7

Cited by 20 publications

(11 citation statements)

References 58 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Depressive symptomatology may be related to the co-existence of a post-psychotic depression, an adjustment disorder secondary to difficulties in psychosocial functioning, or to concomitant medical illnesses or dysphoria secondary to persistent drug abuse. Negative symptoms (especially affective flattening) are frequently and mistakenly confused with depressive symptomatology [15]. These symptoms require an adequate identification and clinical intervention as they are usually associated with poor social and vocational functioning [23] and with increased risk of relapse [7].…”

Section: Discussionmentioning

confidence: 99%

Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: Prevalence and associations in a cross-sectional study

et al. 2007

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: Prevalence and associations in a cross-sectional study

et al. 2007

View full text Add to dashboard Cite

show abstract

“…In order to take into account findings from literature [56][57][58][59] that comorbid depression occurs approximately in 50% of patients with schizophrenia at some point in the course of the disorder, we also analyzed the relation of affective symptoms to safe distancing. We found that affective symptoms (PANSS anxiety, tension, and motor retardation items) were associated with safer distancing from threat-related figures, confirming previous findings that mood-related disorders (anxiety and depression) are closely related to certain problems in emotion regulation [9,10,19] , especially to focusing on the inability to separate oneself from threatening situations [60] .…”

Section: Distancing and Symptomatologymentioning

confidence: 99%

Interpersonal distances, coping strategies and psychopathology in patients with depression and schizophrenia

Ponizovsky

Finkelstein²,

Poliakova³

et al. 2013

WJP

View full text Add to dashboard Cite

AIM:To explore (1) intergroup differences in comfortable interpersonal distances (CIDs) and the use of coping strategies; (2) the association of these parameters with individual symptomatology; and (3) the interplay between CIDs and coping styles in patients with depression and schizophrenia. METHODS:The parameters of interest were assessed by means of standardized questionnaires: CID and Coping Inventory for Stressful Situations. Psychopathology was evaluated with the Beck Depression Inventory and Positive and Negative Syndromes Scale. ANOVA, Pearson's correlations and multiple regression analyses were used to examine relationships among the variables. RESULTS:Compared with controls, depressed patients were more distanced from family members, significant others and self-images, whereas patients with schizophrenia were less distanced from neutral and threatrelated stimuli. Distancing from self-images was mostly associated with depression severity in depressed patients, whereas distancing from hostile and threat-related stimuli with the severity of psychotic and affective symptoms in patients with schizophrenia. Both patient groups used more emotion-oriented than task-oriented and avoidance-oriented coping strategies. Self-distancing among patients with schizophrenia was positively associated with the use of the social diversion coping, implying social support seeking. CONCLUSION:Patients with depression and schizophrenia use different maladaptive emotion -regulation strategies to cope with their symptoms and related distress. Training in stress management might provide these patients with skills for more effective emotion regulation.© 2013 Baishideng Publishing Group Co., Limited. All rights reserved.Key words: Interpersonal distance; Coping strategies; Psychopathology; Depression; Schizophrenia Core tip: This paper takes a unique approach by investigating two emotion-regulation strategies, interpersonal distancing and coping with stress, in patients diagnosed with both adjustment disorder with depression and schizophrenia, and the relationships of these strategies to symptomatology of the disorders. The findings generally supported the hypotheses that the patient groups would display greater interpersonal distances from both positively and negatively valenced stimuli, and greater use of emotion-focused coping than controls. The findings suggest that patients with depression and schizophrenia use different maladaptive emotion-regulation BRIEF ARTICLE

show abstract

“…Depressive symptoms frequently emerge during acute psychotic exacerbations (Tapp et al, 2001) or shortly after resolution of acute positive symptoms (e.g. postpsychotic depression) (Kohler and Lallart, 2002). Over time, they tend to manifest independently of positive symptoms, and may therefore occur at any stage of the illness.…”

Section: Mortality Owing To Suicide Backgroundmentioning

confidence: 99%

Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment

Altamura

Bobo

Meltzer

2007

International Clinical Psychopharmacology

View full text Add to dashboard Cite

A major focus of current treatment research in schizophrenia is the determinants of long-term outcome, including functional outcome and general medical well being, rather than just specific domains of psychopathology such as positive and negative symptoms, mood symptoms, and cognitive impairment. This focus does not negate the importance of the latter issues but sees them as factors contributing to long-term outcome to variable extents. A long-term treatment focus facilitates a more clinically relevant assessment of benefits versus risks of available treatments. For instance, atypical antipsychotic drugs as a group have clear advantages for several important domains of efficacy that may influence long-term outcome, but are also more expensive over the long term. Use of some agents may also result in deleterious physical health consequences as well as large additional costs over the long term owing to metabolic adverse effects. The present paper focuses on several key issues in schizophrenia which are important determinants of long-term outcome in schizophrenia, or influence choice of antipsychotic drugs, or both, including: (i) duration of untreated psychosis; (ii) impact of relapse on long-term outcome; (iii) limited efficacy for specific domains of psychopathology of current treatments; (iv) mortality owing to suicide; and (v) mortality owing to other causes (e.g. cardiovascular disease).

show abstract

Postpsychotic depression in schizophrenia patients

Cited by 20 publications

References 58 publications

Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: Prevalence and associations in a cross-sectional study

Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: Prevalence and associations in a cross-sectional study

Interpersonal distances, coping strategies and psychopathology in patients with depression and schizophrenia

Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment

Contact Info

Product

Resources

About